Fresenius Medical Care AG (FMS)
NYSE: FMS · Real-Time Price · USD
23.43
0.00 (0.00%)
Aug 21, 2026, 4:00 PM EDT - Market closed

Fresenius Medical Care AG Cash Flow Statement

Millions EUR. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
937.78978.37537.91499673.41969.31
Depreciation & Amortization
1,3671,4001,4831,6131,7201,585
Other Amortization
63.2463.2452.7---
Loss (Gain) From Sale of Assets
72.94123.24-12.17-12.9-99.2744.09
Asset Writedown & Restructuring Costs
127.0237206.72139.24118.2338.31
Loss (Gain) on Equity Investments
-88.43-181.37-134.88-121.79-66.56-92.18
Other Operating Activities
170.75122.12-191.3-48.76-50.542.37
Change in Accounts Receivable
-88.99-69.06-73.48-151.84-46.68-163.2
Change in Inventory
-326.18-248.66107.9-13.14-204.31-48.53
Change in Accounts Payable
256.9412.45155.59108.48-356.79-363.96
Change in Income Taxes
287.78236.61482.27472.08325.68313.71
Change in Other Net Operating Assets
50.98206.9-227.97145.7154.03164.2
Operating Cash Flow
2,8302,6812,3862,6292,1672,489
Operating Cash Flow Growth
2.77%12.36%-9.23%21.29%-12.94%-41.19%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-1,046-915.37-699.36-684.6-723.99-854.36
Sale of Property, Plant & Equipment
13.4716.714.116.1436.2124.42
Cash Acquisitions
-6.38-15.3-0.18-3.1410.53-324.81
Divestitures
182.96202.14629.75172.260.1652.44
Sale (Purchase) of Intangibles
-4.67-4.67-8.54-26.37-46.35-32.36
Investment in Securities
-52.17-6.03-20.71-18.46-71.28-61.58
Investing Cash Flow
-912.48-722.53-84.94-544.23-734.73-1,196

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-156.4684.8165.34717.091,804
Long-Term Debt Issued
-1,62361.51417.881,0821,244
Total Debt Issued
1,1911,779146.33483.211,7993,048
Short-Term Debt Repaid
--140.81-540.5-244.98-1,302-627.25
Long-Term Debt Repaid
--1,489-1,534-1,497-1,520-2,780
Total Debt Repaid
-1,673-1,629-2,075-1,742-2,822-3,407
Net Debt Issued (Repaid)
-481.92149.58-1,928-1,259-1,023-358.9
Issuance of Common Stock
----20.156.51
Repurchase of Common Stock
-1,077-585.29----
Common Dividends Paid
-400.16-422.52-349.16-328.62-395.56-392.46
Other Financing Activities
-589.93-544.99-291.89-270.75-218.91-279.54
Financing Cash Flow
-2,549-1,403-2,569-1,859-1,617-1,024

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-27.58-141.4826.2-72.61-23.16131.23
Net Cash Flow
-658.89413.79-241.9153.44-207.87400.12

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
1,7851,7661,6871,9441,4431,635
Free Cash Flow Growth
-12.85%4.67%-13.24%34.70%-11.73%-48.60%
Free Cash Flow Margin
9.19%9.00%8.72%9.99%7.44%9.28%
Free Cash Flow Per Share
6.376.065.756.634.925.58
Levered Free Cash Flow
2,0221,5562,0311,3121,0231,697
Unlevered Free Cash Flow
2,2621,7972,2861,5781,2481,918

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
350.67359.98381.23394.54350.68341.63
Cash Income Tax Paid
213.15225.75444.59410.13334.62345.05
Change in Working Capital
180.52138.24444.31561.28-128.07-97.77
SEC Filings: 10-K · 10-Q